[
  {
    "ts": null,
    "headline": "CVS Health (CVS) Stock Slides as Market Rises: Facts to Know Before You Trade",
    "summary": "In the most recent trading session, CVS Health (CVS) closed at $58.75, indicating a -5.01% shift from the previous trading day.",
    "url": "https://finnhub.io/api/news?id=7d1d25545a70ba015588f44a3b7a8f196ea72fe4f553cc01623afe0d6a6e5bcb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753393502,
      "headline": "CVS Health (CVS) Stock Slides as Market Rises: Facts to Know Before You Trade",
      "id": 136085253,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "In the most recent trading session, CVS Health (CVS) closed at $58.75, indicating a -5.01% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=7d1d25545a70ba015588f44a3b7a8f196ea72fe4f553cc01623afe0d6a6e5bcb"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly and Company (LLY): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Eli Lilly and Company on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company’s share was trading at $798.89 as of July 23rd. LLY’s trailing and forward P/E were 65.00 and 36.63 respectively according to Yahoo Finance. Eli Lilly remains […]",
    "url": "https://finnhub.io/api/news?id=ddc0477f2b31c985e9db2d509c7217e37eb6e596180b932cea4395f6485d426c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753387472,
      "headline": "Eli Lilly and Company (LLY): A Bull Case Theory",
      "id": 136084780,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on Eli Lilly and Company on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company’s share was trading at $798.89 as of July 23rd. LLY’s trailing and forward P/E were 65.00 and 36.63 respectively according to Yahoo Finance. Eli Lilly remains […]",
      "url": "https://finnhub.io/api/news?id=ddc0477f2b31c985e9db2d509c7217e37eb6e596180b932cea4395f6485d426c"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Corp. stock underperforms Thursday when compared to competitors",
    "summary": "CVS Health Corp. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=d13f0d9cbb184673376b162a77323cc541a0d7de7d82e40a7882cd44876f6a13",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753375380,
      "headline": "CVS Health Corp. stock underperforms Thursday when compared to competitors",
      "id": 136125602,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "CVS Health Corp. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=d13f0d9cbb184673376b162a77323cc541a0d7de7d82e40a7882cd44876f6a13"
    }
  },
  {
    "ts": null,
    "headline": "CVS or DHR: Which Is the Better Value Stock Right Now?",
    "summary": "CVS vs. DHR: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=c3c8fc4d56ac4733e32f0848bd50e15d4643e3b9a1ff1c249f4bcfe80d28c3a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753371603,
      "headline": "CVS or DHR: Which Is the Better Value Stock Right Now?",
      "id": 136085146,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS vs. DHR: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=c3c8fc4d56ac4733e32f0848bd50e15d4643e3b9a1ff1c249f4bcfe80d28c3a1"
    }
  },
  {
    "ts": null,
    "headline": "Can Robust Invisalign Momentum Drive Align Technology's Q2 Earnings?",
    "summary": "ALGN is likely to have delivered robust Q2 2025 performance as Invisalign traction and iTero upgrades gained steam across global markets.",
    "url": "https://finnhub.io/api/news?id=c913f1f8e73dd53bc7c4a5916e89aa38267272a8abc06dda0ca85d1676c55f62",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753366080,
      "headline": "Can Robust Invisalign Momentum Drive Align Technology's Q2 Earnings?",
      "id": 136085256,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "ALGN is likely to have delivered robust Q2 2025 performance as Invisalign traction and iTero upgrades gained steam across global markets.",
      "url": "https://finnhub.io/api/news?id=c913f1f8e73dd53bc7c4a5916e89aa38267272a8abc06dda0ca85d1676c55f62"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health (CVS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release",
    "summary": "CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=5533fb8b2dbcbe4c4d343c861efad6d338eeee3aa193e4ae16fd7d3ee9ad876c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753365612,
      "headline": "CVS Health (CVS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release",
      "id": 136067359,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=5533fb8b2dbcbe4c4d343c861efad6d338eeee3aa193e4ae16fd7d3ee9ad876c"
    }
  },
  {
    "ts": null,
    "headline": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
    "summary": "Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.",
    "url": "https://finnhub.io/api/news?id=a24737b1672003bf38c3a646db61f52b65141d00d36584f8676eb3e70bbbe918",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753362002,
      "headline": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
      "id": 136066562,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.",
      "url": "https://finnhub.io/api/news?id=a24737b1672003bf38c3a646db61f52b65141d00d36584f8676eb3e70bbbe918"
    }
  }
]